{"id":4312,"date":"2023-09-09T16:00:36","date_gmt":"2023-09-09T16:00:36","guid":{"rendered":"https:\/\/regtechafrica.com\/healthcare\/?p=4312"},"modified":"2023-09-09T16:00:36","modified_gmt":"2023-09-09T16:00:36","slug":"global-uk-healthcare-watchdog-approves-eli-lillys-diabetes-drug-mounjaro","status":"publish","type":"post","link":"https:\/\/regtechafrica.com\/healthcare\/global-uk-healthcare-watchdog-approves-eli-lillys-diabetes-drug-mounjaro\/","title":{"rendered":"Global: UK Healthcare Watchdog Approves Eli Lilly&#8217;s Diabetes Drug Mounjaro"},"content":{"rendered":"<p>Eli Lilly&#8217;s diabetes medication, Mounjaro, has received the endorsement of the UK&#8217;s healthcare cost-effectiveness authority, which deems it a promising option for individuals with poorly managed type 2 diabetes.<\/p>\n<p>The National Institute for Health and Care Excellence (NICE), in its draft final guidance, estimated that approximately 180,000 patients could benefit from this novel treatment.<\/p>\n<p>Mounjaro, also known as tirzepatide, has garnered attention for its potential in addressing obesity as well. A decision regarding its use for weight loss in the United States is expected later this year, leading to a surge in Lilly&#8217;s stock price as investors anticipate blockbuster status for the drug.<\/p>\n<p>The final guidance from NICE is set to be released on October 11, following which the drug will be accessible within the UK&#8217;s National Health Service (NHS) within 90 days. NICE serves as the government agency responsible for assessing whether medicines should be integrated into the NHS.<\/p>\n<p>Notably, in July, NICE had requested additional data from Lilly concerning the drug&#8217;s benefits.<\/p>\n<p>This development coincides with nationwide shortages of Novo Nordisk&#8217;s Ozempic, which belongs to the same drug class as Mounjaro and is approved in the UK for type 2 diabetes treatment.<\/p>\n<p>As of now, Eli Lilly has not provided an immediate response to Reuters&#8217; request for comment.<\/p>\n<p>Diabetes UK, an advocacy organization, conveyed to Reuters this week that the increasing &#8220;off-label&#8221; usage of Ozempic for weight loss has negatively impacted individuals with type 2 diabetes who were prescribed the drug but encountered difficulties obtaining their prescriptions.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Eli Lilly&#8217;s diabetes medication, Mounjaro, has received the endorsement of the UK&#8217;s healthcare cost-effectiveness authority, which deems it a promising option for individuals with poorly managed type 2 diabetes. The&hellip;<\/p>\n","protected":false},"author":1,"featured_media":4315,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[73,78],"tags":[],"class_list":["post-4312","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-global","category-regulatory"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/regtechafrica.com\/healthcare\/wp-content\/uploads\/2023\/09\/Lillys-diabetes-drug-Mounjaro-approved-by-UK-watchdog.jpg?fit=1200%2C675&ssl=1","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/posts\/4312","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/comments?post=4312"}],"version-history":[{"count":1,"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/posts\/4312\/revisions"}],"predecessor-version":[{"id":4316,"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/posts\/4312\/revisions\/4316"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/media\/4315"}],"wp:attachment":[{"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/media?parent=4312"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/categories?post=4312"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/tags?post=4312"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}